1.A clinical observation on 143 cases of hemorrhoids.
Ho Yeong RHYU ; Jung Hun KIM ; Nam Poo KANG
Journal of the Korean Surgical Society 1991;41(1):100-106
No abstract available.
Hemorrhoids*
2.Expression of p53 Protein in Gastric Adenoma and Carcinom.
So Yeong OH ; Myoung Jae KANG ; Dong Geun LEE ; Ho Youl CHOI ; Sang Ho KIM
Korean Journal of Pathology 1996;30(10):886-892
In the present study, immunohistochemical detection of p53 oncoprotein was performed to determine whether the grade of differentiation and the histologic type of gastric adenocarcinoma, and the degree of atypia accompanied with adenoma can be related to p53 mutation. Paraffin sections of 22 gastric adenomas and 56 gastric adenocarcinomas were examined for the overexpression of p53 oncoprotein with the avidin-biotin peroxidase complex staining procedure. The obtained results were as follows; 1. All the 22 cases of adenomas and 16 cases of well differentated adenocarcinomas showed uniformly negative staining. 2.Seven of 18 cases of moderately differentiated adenocarcinomas(39%), and five of 30 cases of poorly differentiated adenocarcinomas(17%) exhibited p53 protein expression. 3. Three of 29 cases of diffuse type (10%) and 9 of 19 cases of intestinal type(47%) exhibited p53 protein expression. These results suggest that p53 mutation is important in carcinogenesis of the intestinal type of gastric adenocarcinoma, and there is no correlation between the differentiation of gastric adenocarcinoma and the degree of p53 oncoprotein overexpression.
Adenocarcinoma
;
Adenoma
3.A Case of Apert's Syndrome.
In Kwyu PARK ; Kang Ho KIM ; Yeong Bong PARK ; Jin Heon KIM ; Chang Soo RA
Journal of the Korean Pediatric Society 1986;29(9):74-78
No abstract available.
4.Serum IgE level in children with minimal change nephrotic syndrome and its clinical significance.
Jong Bum SHIN ; Byeong Ho KANG ; Woo Yeong CHUNG ; Soon Yong LEE
Korean Journal of Nephrology 1992;11(2):115-118
No abstract available.
Child*
;
Humans
;
Immunoglobulin E*
;
Nephrosis, Lipoid*
5.Correlation between Expression of Insulin-like Growth Factor-I Receptor and Clinicopathologic Prognostic Factors in Invasive Ductal Carcinoma of the Breast.
So Yeong OH ; Myoung Jae KANG ; Woo Sung MOON ; Ho Yeul CHOI
Journal of Korean Breast Cancer Society 2002;5(2):118-124
PURPOSE: The insulin-like growth factor-I receptor (IGF-IR) is a member of the transmembrane tyrosine kinase family that regulates various biological processes. These processes include maintaining optimal cell growth, establishing and maintaining the transformed phenotype, tumorigenesis for several types of cells, and antiapoptosis. This study investigated the immunohistochemical expression of IGF-IR in relation with the expression of the estrogen receptor (ER), the progesteron receptor (PR), proliferative activity (Ki-67) as well as with the other conventional clinicopathlogical parameters in breast cancer. METHODS: This study was performed on paraffin sections from 64 invasive ductal breast carcinoma specimens by immunohistochemistry using rabbit polyclonal antibodies to the IGF-I receptor. RESULTS: IGF-IR expression was detected in 56 (87.5%) cases. The immunohistochemical stains for the IGF-IR were scored according to a semi quantitative scoring system. IGF-IR staining was positively correlated with the ER status, but not significantly with the PR, lymph node status, tumor size, histological grade, and proliferative activity. The Ki-67 labeling index showed a significant correlation with the tumor grade and ER status. CONCLUSION: The IGF-IR may play a role in estrogen-mediated growth and the pathogenesis of breast cancer.
Antibodies
;
Biological Processes
;
Breast Neoplasms
;
Breast*
;
Carcinogenesis
;
Carcinoma, Ductal*
;
Coloring Agents
;
Estrogens
;
Humans
;
Immunohistochemistry
;
Lymph Nodes
;
Paraffin
;
Phenotype
;
Protein-Tyrosine Kinases
;
Receptor, IGF Type 1
6.Three cases of advanced tubal pregnancy.
Sung Fan JUN ; Kyong Hee YANG ; Keong Hoon CHO ; Jong Kyou PARK ; Yeong Ho KANG
Korean Journal of Obstetrics and Gynecology 1992;35(3):425-428
No abstract available.
Female
;
Pregnancy
;
Pregnancy, Tubal*
7.Adrenal Pseudocyst as a Result of Longterm Intake of Steroid Hormone.
Woo Sung MOON ; So Yeong OH ; Myoung Jae KANG ; Dong Geun LEE ; Ho Yeul CHOI ; Sang Ho KIM
Korean Journal of Pathology 1996;30(4):355-357
Adrenal pseudocysts are uncommon lesions which usually occur as a result of hemorrhage within the adrenal tissue. Adrenal hemorrhage is usually associated with severe stress, sepsis, pregnancy, syphilis, leukemia, or anticoagulant therapy but during steroid therapy, it is very rare. We report a case of adrenal pseudocyst that resulted from hemorrhage into the adrenal gland and is probably related to the exogenous administration of steroids. The patient was a 57-year-old woman who was treated with oradexon for 20 years for the treatment of a maculopapular lesion on her thigh as well as for arthritis. She underwent a right adrenalectomy due to the adrenal cystic mass. The wall of the cystic mass was composed of a thick layer of hyalinized fibrous tissue with remnants of adrenal cortical tissue on the outer aspect. The inner surface had no lining cells and the wall of the cyst contained many calcified plaques with hemosiderin pigment.
Pregnancy
;
Female
;
Humans
;
Cysts
8.A Clinical and Pathological Analysis of Children with Membranoproliferative Glomerulonephritis According to the Clinical Manifestations at Presentation.
Chang Ho JEON ; Mi Seon KANG ; Woo Yeong CHUNG
Journal of the Korean Society of Pediatric Nephrology 2004;8(2):186-194
PURPOSE: Membranoproliferative glomeulonephritis(MPGN) has been diagnosed in an increasing number of asymptomatic cases. These cases have been detected by school urinary screening test even though the total cases of MPGN show a decreasing trend. We have analyzed the clinical and pathological characteristics of children with MPGN according to the clinical manifestations at the time of disease presentation. METHODS: A total of 18 patients who had been diagnosed with idiopathic MPGN by percutaneous renal biopsy from January 1990 to February 2004 were involved in our study. The patients were divided into 2 groups as the school urinary screening(A) group and the symptomatic(S) group according to the clinical manifestations at the time of disease presentation. RESULTS: Out of the total 18 patients, 8(44.4%) were in the S group and 10(55.6%) were in the A group. The mean serum total protein, albumin and C3 levels in the S group were significantly lower than those levels of the A group, respectively(4.9+/-1.2 g/dL vs 7.0+/-0.5 g/dL P=0.002, 2.8+/-0.9 g/dL vs. 4.1+/-0.3 g/dL P=0.002, 63.9+/-36.4 mg/dl vs. 100.8+/-39.5 g/dl P=0.041). The mean total protein amount of 24 hour collected urine in the S group were significantly higher than that of the A group(3684.0+/-2601.3 mg/m2 vs. 559.4+/-406.9 mg/m2, respectively, P=0.001). Hypocomplementemia was observed in 11(61.1%) out of 18 patients at the time of disease onset, 7(87.5%) in the S group and 4(40%) in the A group. However the hypocomplementemia was decreased in 6(33.3%) out of 18 patients at the time of final follow-up, 3(37.5%) in the S group and 3(30%) in the A group. According to the pathologic type, hypocomplementemia was observed 8 patients(61.5%) with type I disease, 1 patients (100%) with type II disease, 2 patients(50%) in type III disease at the disease onset, but 4 patients(30.8%) in type I disease, 1 patient(100%) in type II disease, 1 patient(33.3%) with type III disease at the time of last follow-up. The incidence of cellular crescent formation and tubular atropy, as observed on light microscopy, were higher in the S group compared to the A group. Mean grade of capillary wall thickening and, mesangial proliferation were significantly higher in the S group. CONCLUSION: MPGN, as diagnosed in patients with only asymptomatic urinary abnormalities, has been increasing, it is more frequent in asymptomatic patients than in patients with presenting symptoms. Our result suggests that MPGN should be considered in the renal biopsy diagnosis regardless of serum C3 level when urinary abnormalities are found by school urinary screening test.
Biopsy
;
Capillaries
;
Child*
;
Diagnosis
;
Follow-Up Studies
;
Glomerulonephritis, Membranoproliferative*
;
Humans
;
Incidence
;
Mass Screening
;
Microscopy
9.Correlation between Expression of Insulin-like Growth Factor-I Receptor and Clinicopathologic Prognostic Factors in Invasive Ductal Carcinoma of the Breast.
So Yeong OH ; Myoung Jae KANG ; Woo Sung MOON ; Ho Yeul CHOI
Journal of the Korean Surgical Society 2002;62(5):396-402
PURPOSE: The insulin-like growth factor-I receptor (IGF-IR) is a member of the transmembrane tyrosine kinase family that regulates various biological processes. These processes include maintaining optimal cell growth, establishing and maintaining the transformed phenotype, tumorigenesis for several types of cells, and antiapoptosis. This study investigated the immunohistochemical expression of IGF-IR in relation with the expression of the estrogen receptor (ER), the progesteron receptor (PR), proliferative activity (Ki-67) as well as with the other conventional clinicopathlogical parameters in breast cancer. METHODS: This study was performed on paraffin sections from 64 invasive ductal breast carcinoma specimens by immunohistochemistry using rabbit polyclonal antibodies to the IGF-I receptor. RESULTS: IGF-IR expression was detected in 56 (87.5%) cases. The immunohistochemical stains for the IGF-IR were scored according to a semi quantitative scoring system. IGF-IR staining was positively correlated with the ER status, but not significantly with the PR, lymph node status, tumor size, histological grade, and proliferative activity. The Ki-67 labeling index showed a significant correlation with the tumor grade and ER status. CONCLUSION: The IGF-IR may play a role in estrogen-mediated growth and the pathogenesis of breast cancer.
Antibodies
;
Biological Processes
;
Breast Neoplasms
;
Breast*
;
Carcinogenesis
;
Carcinoma, Ductal*
;
Coloring Agents
;
Estrogens
;
Humans
;
Immunohistochemistry
;
Lymph Nodes
;
Paraffin
;
Phenotype
;
Protein-Tyrosine Kinases
;
Receptor, IGF Type 1